• Circulating Tumor Cells (CTC), Lung Cancer
  • Dopamine receptor 1 (DRD1) Genotyping
  • Intrinsic Factor Blocking Antibody
  • Valproic Acid, Free and Total, Serum
  • Neurotrophic Receptor Tyrosine Kinase 3 (NTRK3) Gene Mutation Analysis (Translocation)
  • Guardant360 TissueNextâ„¢, Lung and Breast Cancer Therapy Management
  • Cystatin C, Serum
  • Hemoglobin, Free, Plasma
  • Carcinoembryonic Antigen (CEA), Peritoneal Fluid
  • Chikungunya Virus RNA, Real-Time PCR, Qualitative
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Multiple Endocrine Neoplasia Type 1 (MEN1) Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Multiple Endocrine Neoplasia Type 1 (MEN1) Mutation Analysis
Medical Test

Clinical Utility
Access to Multiple Endocrine Neoplasia Type 1 (MEN1) Mutation Analysis is restricted.
Loading...